That Marketing Solution Inc (OTCBB:TSTS) has seen a massive surge or volume and the price has begun to move up since the stock traded as low as $0.00 bid. The last real run this one made was back in November after they announced they had successfully micellized CBD oil and are exploring options to monetize this development.
TSTS is a stock with a long history of big moves running from pennies to highs over $0.50 last year. The whole thing collapsed after blocks of convertible debt hit the market and decimated the share price.
That Marketing Solution Inc (OTCBB:TSTS) is a digital branding Company that develops and markets products in a number of different industries including health & wellness. The company owns and operates Technology around Micellization Manufacturing Process. This Proprietary Micellization Process converts oil based nutrients into water soluble products for better absorption by the cells.
TSTS has been on fire since they announced they have successfully micellized CBD oil and are exploring options to monetize this development.
CEO Matt Smith said “We have hundreds of man hours in perfecting the micellization of CBD oil. This development is huge in our opinion for this billion-dollar market and we believe our micellized CBD oil will be shortly validated as the gold standard and the only real smart option for consumers and marketers of CBD products. Our micellized CBD will allow for flavoring options and delivery methods not currently available while increasing bioavailability.”
CBD is a phytocannabinoid that is found in industrial hemp and marijuana, which are two different varieties of the Cannabis sativa plant. The current market for CBD as a dietary supplement is based on industrial hemp, not marijuana, because marijuana also contains significant amounts of tetrahydrocannabinol (THC), a phytocannabinoid that is psychoactive and capable of making a person high.
To Find out the inside Scoop on TSTS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Back in November of last year TSTS made an acquisition that would transform their future when they acquired Aqua V Micellization Technology — a proprietary nutritional breakthrough that makes it possible to adapt fat-soluble compounds into water-soluble compounds outside of the body, effectively increasing bioavailability. The Company said at the time ”The Aqua V Technology is an important scientific discovery that exponentially increases the nutritional benefits of bio-nutrients to the body, while lowering the amount of raw ingredients required to manufacture the nutritional formula.
Many of the most important bio-nutrients that people supplement in their diets are fat-soluble. Therefore, the body must micellize the supplement by breaking it down — which leaves only a portion of the bio-nutrient available for uptake. By using this proprietary technology to adapt the nutrient outside of the body, the uptake is almost immediate, and the formulation has almost no bio-waste in the process. This allows formulators to use less active ingredient in their formulas to get the maximum benefit, and, it controls the delivery of the exact amount of nutritional value to the body.”
According to TSTS the Aqua V Technology is an important scientific discovery that exponentially increases the nutritional benefits of bio-nutrients to the body, while lowering the amount of raw ingredients required to manufacture the nutritional formula. Many of the most important bio-nutrients that people supplement in their diets are fat-soluble. Therefore, the body must micellize the supplement by breaking it down — which leaves only a portion of the bio-nutrient available for uptake.
By using this proprietary technology to adapt the nutrient outside of the body, the uptake is almost immediate, and the formulation has almost no bio-waste in the process. This allows formulators to use less active ingredient in their formulas to get the maximum benefit, and it controls the delivery of the exact amount of nutritional value to the body.
On January 13 TSTS announced their micellized CBD oil is currently undergoing a bioavailability study to prove its superior bioavailability over other options.
TSTS President Matt Smith said the following, “We’re very excited about this bioavailability study and believe it will validate our micellized CBD oil as the new gold standard in the industry.” Mr. Smith also stated, “This study could be a key tool in helping us and key partners monetize our micellized CBD oil.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently moving up in sub penny land TSTS has minimal assets or revenues and rising short term debt that has resulted in significant dilution in the past. The silver lining is there will be no more dilution until December 15 according to a recent 8k. TSTS was an exciting story in small caps; the Company has reinvented itself with an important breakthrough in the exploding CBD oil space announcing they successfully micellized CBD oil. We will be updating on TSTS when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TSTS.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in TSTS either long or short and we have not been compensated for this article.